Probiotix Health PLC - New Partnership Agreement in Belgium
ProBiotix Health plc
("ProBiotix" or the "Company")
New Partnership Agreement in
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is delighted to announce a new partnership agreement with
ProBiotix has secured a commercial cooperation with Nutrisan to supply its patented probiotic strain LPLDL® for a new standalone product launched under the Nutrisan PRO brand, targeted at pharmacists and healthcare professionals across
The agreement marks ProBiotix's entry into the Belgian market and further expands the Company's European commercial footprint, supporting its strategy of partnering with premium nutraceutical brands and extending the reach of LPLDL® through healthcare professional channels.
After an extensive evaluation of clinically substantiated ingredients in the cardiometabolic space, Nutrisan selected LPLDL® for its robust, peer-reviewed clinical evidence supporting healthy cholesterol levels and its differentiated mechanism of action. Within the Nutrisan PRO supplement range, LPLDL® is available as a 60-capsule pack, providing healthcare practitioners and consumers with an evidence-based, single-strain probiotic option to support healthy cholesterol metabolism.
Nutrisan is committed to investing in the long-term growth of LPLDL® in
Cardiovascular disease is one of
"Healthcare professionals, pharmacists and consumers quite rightly demand a high standard of product, and through this partnership we expect to continue to increase our market awareness through the proven benefits of using LPLDL®.
"Thanks to its unique mechanism of action via the gut microbiome, LPLDL® represents a new generation of probiotics that perfectly aligns with our vision: scientifically validated ingredients that offer real added value for both healthcare professionals and consumers."
This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the
[1] Sources: Statista; PMC (Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in
For further information, please contact:
|
ProBiotix Health plc |
|
|
|
|
|
|
|
|
|
|
|
AlbR Capital Limited Aquis Corporate Adviser and Broker |
Tel: 020 7469 0930 |
|
|
|
Notes to Editors:
ProBiotix Health is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.
The Company has a unique approach; discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.
About Nutrisan
Nutrisan is a
Nutrisan's portfolio spans cardiovascular and metabolic health, immune support, cognitive health and general wellbeing, distributed through a network of specialists, general practitioners, pharmacists and paramedics across
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE